bluebird bio, Inc.
DIMERIZING AGENT REGULATED IMMUNORECEPTOR COMPLEXES

Abstract:

The present disclosure provides improved compositions for adoptive T cell therapies for treating, preventing, or ameliorating at least one symptom of a cancer, infectious disease, autoimmune disease, inflammatory disease, and immunodeficiency, or condition associated therewith.